期刊文献+

阻断ERK2信号转导通路对血小板源生长因子-BB诱导血管平滑肌细胞增殖、迁移和表达转化生长因子-β1的影响 被引量:5

Impact of ERK2 signaling pathway blockade on platelet-derived growth factor-induced vascular smooth muscle cells proliferation,migration and transform growth factor-β1 expression
原文传递
导出
摘要 目的观察ERK2信号转导通路在血小板源生长因子(PDGF—BB)诱导血管平滑肌细胞(VSMC)增殖、迁移和表达转化生长因子(TGF)-β1中的作用。方法将原代培养的大鼠VSMC分为4组:(1)对照组;(2)PDGF刺激组;(3)Ad—LacZ组;(4)Adanti—ERK2组。用Western blot检测细胞磷酸化ERK2蛋白水平;噻唑蓝(MTF)比色法测定细胞增殖率;流式细胞仪检测细胞细胞周期;Boyden小室测定细胞的跨膜迁移能力;酶联免疫吸附试验(ELISA)法检测细胞培养液上清中TGF—β1的浓度。结果Adanti-ERK2组和对照组细胞增殖率、S期细胞百分比及跨膜迁移细胞数目明显低于PDGF刺激组和Ad—LacZ组(细胞增殖率:2.75%、0.00%比64.45%、61.88%;S期细胞百分比:14.18%、13.58%比38.14%、32.99%;跨膜迁移细胞数:8.2±3.2、6.3±2.6比24.8±6.1、23.3±5.8,均P〈0.05);(2)Adanti—ERK2组和对照组细胞培养上清液中TGF-β1含量明显低于PDGF刺激组和Ad—LacZ组(P〈0.05);而Adanti—ERK2组明显高于对照组(P〈0.05)。结论ERK2信号转导通路参与调控PDGF—BB诱导的VSMC增殖、迁移和基因表达。反义ERK2基因预先转染阻断ERK信号转导能显著抑制PDGF-BB刺激的VSMC增殖、迁移,阻断细胞周期由G1期进入S期,并且部分下调TGF—β1的合成分泌。 Objective To investigate the effects of ERK pathway on the proliferation, migration and TGF-β1 expression of vascular smooth muscle cells (VSMC) induced by platelet-derived growth factor (PDGF-BB). Methods Primary cultured rat VSMCs were divided into control group, PDGF-BB group (stimulated by 10μg/L PDGF-BB) , Ad-LacZ group (intervened by Ad-LacZ + PDGF-BB) and Adanti- ERK2 group ( intervened by Adanti-ERK2 + PDGF-BB). The phosphorylated protein level of ERK2 was determined by Western blot analysis. The proliferative effect of the cells was evaluated by MTT. The distributon of cell cycle was detected by flow cytometry. The cell migration was measured by the Boyden chamber. The TGF-β1 expression was assayed by ELISA. Results The proliferative rate ,S stage percentage and migrated cell number in Adanti-ERK2 group and control group were all significantly reduced as compared with those in PDGF group and Ad-LaeZ group ( all P 〈 0.05 ). The supernatant TGF-β1 levels in Adanti-ERK2 group and control group were both significantly lower than those in PDGF group and AdLacZ group;the TGF-β1 levels in Adanti-ERK2 group were higher than in control group P 〈 0.05 ). Conclusion The blockade of ERK signaling pathway by Adanti-ERK2 dominantly inhibited the proliferation and migration, arrested cells in G1 phase and partially down-regulated TGF-β1 expression in VSMCs stimulated with PDGF-BB. ERK signaling pathway participates in PDGF-BB induced VSMCs proliferation, migration and gene expression.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2008年第11期1424-1426,共3页 Chinese Journal of Experimental Surgery
基金 国家自然科学基金资助项目(30300324)
关键词 胞外信号调节激酶 血管平滑肌细胞 增殖 迁移 转化生长因子β1 ERK VSMC Proliferation Migration TGF-β1
  • 相关文献

参考文献18

  • 1Avery RK. Cardiac-allograft vasculopathy. N Engl J Med,2003,349: 829-830.
  • 2Sterpetti AV, Cucina A, Lepidi S, et al. Progression and regression of myointimal hyperplasia in experimental vein grafts depends on platelet-derived growth factor and basic fibroblastic growth factor production. J Vasc Surg, 1996,23:568-575.
  • 3Reilly CF, McFall RC. Platelet-derived growth factor and transforming growth factor-β1 regulate plasminogen activator inhibitor-1 synthesis in vascular smooth muscle cells. J Biol Chem, 1991,266:9419-9427.
  • 4Zegarska J, Paczek L, Pawlowska M, et al. Increased mRNA expression of transforming growth factor beta in the arterial wall of chronically rejected renal allografts in humans. Transplant Proc ,2006,38:115- 118.
  • 5Geraldes P, Sirois MG, Tanguay JF. Specific contribution of estrogen receptors on mitogen-activated protein kinase pathways and vascular cell activation. Circ Res,2003,93:399405.
  • 6董冲,刘云,宫念樵,陈曦林,唐莉,朱国超,陈知水,叶启发.反向克隆法大鼠anti-ERK2腺病毒载体构建[J].中国现代医学杂志,2006,16(1):21-23. 被引量:4
  • 7Majack RA. Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures. J Cell Biol, 1987,105:465-471.
  • 8Huang J,Kontos CD. Inhibition of vascular smooth muscle cell proliferation, migration, and survival by the tumor suppressor protein PTEN. Arterioseler Thromb Vase Biol,2002 ,22 :745-751.
  • 9向志,吴忠均,余林,时德.反义c-myc和增殖细胞核抗原抑制移植血管狭窄研究[J].中华实验外科杂志,2007,24(2):144-146. 被引量:4
  • 10Cartel NJ, Liu J. PDGF-BB-mediated activation of p42 (MAPK) is independent of PDGF beta-receptor tyrosine phosphorylation. Am J Physiol Lung Cell Mol Physiol,2001,281:786-798.

二级参考文献26

  • 1杨军,胡新华,张志深,刘程伟,陈哲,张强.反义寡核苷酸抑制Survivin基因表达对移植静脉内膜增生的影响[J].中华实验外科杂志,2005,22(12):1516-1518. 被引量:8
  • 2FRED L ROBINSON, ANGELIQUE W. WHITEHURST, et al.Identification of Novel Point Mutations in ERK2 That SelectivelyDisrupt Binding to MEK1[J]. Journal of Biological Chemistry,2002, 277: 14844-14852.
  • 3YASUTAKA IKEDA, AKIRA MURAKAMI, HAJIME OHIGASHI.Ursolic acid promotes the release of macrophage migration inhibitory factor via ERK2 activation in resting mouse macrophages[J]. Biochemical Pharmacology, 2005, 8: 1-9.
  • 4PAGES G, GUERIN S, GRALL D, et al. Defective thymocyte maturation in p44 MAPkinase (Erk Ⅰ) knockout mice[J]. Science,1999, 286: 1574-1577.
  • 5Viklieky O, Zou H, Muller V, et al. SDZ-RAD prevents manifestation of chronic rejection in rat renal aUografts. Transplantation, 2000, 69:497-502.
  • 6Koskinen P, Lemstrom K, Hayry P. Chronic rejection. Curr Opin Nephrol Hypertens, 1996, 5 : 269-270.
  • 7Hayry P, Yilmaz S. Role of growth factors in graft vessel disease.Transplant Proc, 1995, 27 : 2066-2067.
  • 8Adkins JR, Castresana MR, Wang Z, et al. Rapamyein inhibits release of tumor necrosis factor-alpha from human vascular smooth muscle cells. Am Surg, 2004, 70 : 384-387.
  • 9Kavsak P, Rasmussen RK, Causing CG, et al. Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF-β receptor for degradation. Mol Cell, 2000, 6:1365-1375.
  • 10Massague J, Blain SW, Lo RS, et al. TGF-beta signaling in growth control, cancer, and heritable disorders. Cell, 2000, 103 : 295-309.

共引文献12

同被引文献22

引证文献5

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部